The inclusion of three additional targets (CCNA2, PCNA, and KIF23) within the APIS BC Subtyping Kit, known to be associated with breast cancer proliferation [20,21,22,23,24] and expressed across all cell cycle stages, allows for the generation of a more complete proliferation measure. The gene discussed is CCNA2; the disease is breast carcinoma.